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ABSTRACT 
In present scenario cancer has become one of the most difficult global healthcare problems, despite of having library of anti-cancer drugs the 
problem remains the same due to no specificity, burst release, damaging of normal cells and numerous side effects.  Nanotechnology the 
emerging field gained attention as it offers site specific treatment in various tumors with lesser side effect. Nano carriers, a transport module 
provide platform to circumvent the problems related with the delivery of anticancer drug in drug delivery systems. Nano carriers help to 
improve the bioavailability and therapeutic efficiency of antitumor drugs, while providing preferential accumulation at the t arget site. Various 
nanocarriers are clinically approved for the delivery of antitumor drugs for their intended actions at the targeted sites. This review illustrates 
about the various nanocarriers, their importance in the delivery of anticancer drugs, targeting mechanisms of nanoparticles, various method of 
preparations of nanoparticles and influence of nanotechnology on herbal drug.  
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1. Introduction  
Globally cancer has been the second leading cause of death, 
and is responsible for an estimated 9.6 million deaths in 
2018.1 Chemotherapy involves rapidly killing and blocking 
of growth of cells in the body. Chemotherapeutics 
encounters the faster growing cancer cells, than the healthy 
ones, however because there are healthy cells which are also 
fast-growing, the drugs used in chemotherapy also attack 
those fast-growing healthy cells. This unwanted attack 
results in the failure of conventional chemotherapy.2 In 
addition; the major drawback to the success of 
chemotherapy is hindered due to multi drug resistance 
(MDR). 3 Prolong uses of these anticancer drug results in 
development of multi drug resistances. The limitations of 
conventional chemotherapy have led to the development to 
target the delivery of drugs specifically to cancer cells 
through directing the cellular events at nanometer scale. 
Where conventional therapies necessitate hundreds or 
thousands of cells to detect the presence of any tumor, 
nanotechnology based approaches could significantly lower 
this requirement, thus making possible much earlier 
diagnosis and treatment regimes.  
Nanoparticles are materials with size ranging from 1 to 1000 
nm. Nanoparticles proceed by active and passive targeting 
strategies for encountering cancerous cells that effectively 
enhance the intracellular concentration of therapeutic drugs 
in the cancerous cells while avoiding toxicity in normal 
cells.4 There are a variety of NP based drug delivery systems 
currently being explored for cancer therapeutics.5 Cancer 
related examples of nano-formulations include organic and 
inorganic nanoparticles. The aim of this paper is to review 
fabrication methods for the most common nanoparticle type, 
its importance and future prospect. 
2. Nanocarriers based drug delivery systems  
Nanocarrier-based drug delivery system enables effective 
delivery of anticancer drugs by hindering the environment 
of cancer cells and exploiting their pathophysiological 
conditions 
2.1 Organic nanocarriers 
1. Solid lipid nanoparticles (SLNs) 
Solid lipid nanoparticles are particle with size range from 50 
nm to 1000 nm. These carriers consist of monolayer 
phospholipid, dispersed in water or in aqueous surfactant 
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ensuring colloidal stability.  Homogenization at high 
pressure and micro emulsification are the two most common 
effective methods used for the preparation of SLNs 
nanoparticles. Solid lipid like fatty acids, waxes, steroids 
provide a highly lipophilic lipid matrix for drugs when 
dissolved or are dispersed in surfactant.6 
SLNs as nanocarriers has been used in  incorporating drug as 
it has various major benefits  like it increases the 
bioavailability of poorly soluble  drugs, reduces toxicity, 
increases efficacy, enhances stability.  
 The composition of SLNs containing lipid, drug and 
surfactant and their preparation method by hot or cold 
homogenization, drug can either be dispersed 
homogeneously in lipid matrix of SLNs (incorporated into 
the shell surrounding the lipid core (drug-enriched shell 
model) or incorporated into the core surrounded by a lipid 
shell (drug-enriched core model).SLNs have been used in 
effectively delivery of various anticancer drug   like 
docetaxel7,doxorubicin8, paclitaxel9, methotrexate10 and 5-
fluorouracil (5-FU)11. 
2. Liposomes 
Liposomes are bilayer or multilayered phospholipid in 
spherical shaped vesicles with polar head groups oriented 
interiorly while non-polar head in the external phase. 
Liposomes have attained great attention because 
biocompatibility, biodegradability, low toxicity, and has 
property to trap both hydrophilic and lipophilic drugs12 with 
less decomposition of the entrapped combinations, and 
release the entrapped at designated targets. 
They showed a number of advantages over conventional 
systems which are, enhanced delivery of drug, protection of 
active drug from environmental factors, improved 
performance features of the product, preventing early 
degradation of the encapsulated drug, cost-effective 
formulations of expensive drugs and efficient treatment with 
reduced systemic toxicity.13 Moreover, liposomes intact 
drugs have altered the pharmacokinetic properties 
compared to free form of drugs. Liposomes are commonly 
used as model cells or carriers for various bioactive agents 
including drugs, vaccines, cosmetics and nutraceuticals. The 
biodegradable and biocompatible composition of liposomes 
made them excellent therapeutic carriers and has increased 
their use in biomedicine formulations.14 
3. Dendrimers 
Dendrimers are nanocarriers associated with central core 
having branched macromolecules.15 Usually, they are 
produced by using natural or synthetic components, which 
include sugars, nucleotides and amino acids. There unique 
size and well-arranged irregular branching patterns are 
obtained by polymerization process 
Dendrimers are branched layer molecules containing 
numerous active terminals and initiator core with diameter 
1.5-14.5 nm16. The synthesis process involves addition of 
new branch to the core is termed as generation. Numerous 
branches are added to the core to make the molecules a 
bulky thus increases helps to increase the linkages of 
drugs17. These nanocarriers usually intact drug molecules 
with hydrogen bonding or through chemical linkages other 
than this various ligand targeting drugs and surface 
functionalized drug are also attached to obtain specific 
objectives, which usually implicate precise contact at cell 
walls and biologically active sites. For preclinical study 
dendrimers came into light in forming dendrimer–drug 
conjugates. Recently, dendrimers have been extensively 
used in fields of biomedicine, including gene delivery, 
immunology, magnetic resonance imaging, vaccines and 
antiviral, antibacterial and anticancer drug delivery18. 
4. Polymeric Nanoparticles (PNPs) 
Polymers nanoparticles are colloidal particles with size 
range of 10 to1000 nm. These particles are made up of 
biodegradable polymer and their structure can be 
categorized into nanospheres or nanocapsule particle19. 
Nanospheres are polymeric particle which can easily entrap 
drug inside the polymer matrix without any degradation20 
whereas in nanocapsule the drug is dissolved in liquid core 
and future is encapsulated by solid polymeric membrane 21. 
Various number of methods like solvent evaporation, salting 
out, nanoprecipitation, dialysis, supercritical fluid 
technology, emulsification polymerization, miniemulsion 
polymerization, microemulsion polymerization have been 
reported for formation of these polymeric nanoparticles 
theses method also include successfully adsorption or 
chemical conjugation of drug on to the surface22.   
2.2 Inorganic nanocarriers 
1. Carbon nanotubes (CNTs) 
The discovery of carbon nanotubes came into lime light in 
1991 by Iijima. These are hollow tube like structured formed 
by graphene sheet belong to family of fullerenes an 
allotropic form of carbon23.  CNTs comprise of cross -
sectional nanometer range dimensions and lengths that can 
extend over a thousand time their diameters. The range of 
these diameters ranges from 0.4–2 nm and 2–100 nm for 
single walled carbon nanotubes and multiwall carbon 
nanotubes respectively. The commonly used convenient 
techniques for the production of CNTs include arc discharge, 
laser ablation and thermal or plasma-enhanced chemical 
vapor deposition24. 
CNTs have promising carrier characteristics which not only 
includes their hollow monolithic structure, but also their 
high mechanical strength, high electrical and thermal 
conductivities and their ability for surface modifications. The 
major drawback with  CNTs as a drug carrier are their poor 
water solubility and toxicity which can be overcome by 
surface functionalized, which make them water soluble, 
biocompatible, non/less toxic and as a serum-stable carrier. 
2. Mesoporous silica nanoparticles (MSNs) 
Mesoporous silica nanoparticles are comb like structure 
which gain interest by researcher due to their massive 
availability of silica as a material and simple synthesis 
procedures. MSNs ranges from 2 to 50 nm in diameter they 
are versatile of loading hydrophilic as well as lipophilic drug 
and also possess s good biocompatibility, large specific 
surface area and pore volume, high loading capacity25 In 
addition, MSNs enables targeted drug delivery with increase 
therapeutic efficacy .Their surface can easily undergo 
functionalization for controlled drug delivery and reduce 
toxicity.  Many anticancer drugs like paclitaxel26, 
camptothecin27, doxorubicin28 and methotrexate29 have 
been loaded in large amount with nanoscale particle range 
in tumor tissue by active as well as passive mechanism and 
as show fruitful result in effective delivery. 
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Fig 1 .Types of nanocarriers for novel drug delivery system 
 
3. Targeting of nanoparticles on cancer cells 
3.1 Passive Targeting  
The abnormal growth of cancer cells increases the demand 
of oxygen and nutrients than that of normal cells through 
blood vessels, which result in forming wide and leaky blood 
vessels around the cells induced by angiogenesis. The 
reduction in number of perivascular lining rapidly 
proliferate endothelial cells resulting in large pores of 100 
nm to 780 nm with leaky blood vessels30. Nanoparticles 
containing drug can easily enter the interstitial area in the 
tumor. This feature is called the enhanced permeability and 
retention (EPR) effect and facilitates tumor interstitial drug 
accumulation. Nanoparticles can easily accumulate 
selectively by enhanced permeability and retention effect 
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3.2.2. Active Targeting 
Nanoparticle with chemotherapeutic agents is designed to 
actively target the cancerous cells. This active targeting is 
based on modification in surface of nanoparticle, ligand 
receptor interaction or antibody-antigen recognition. Active 
targeting is based on molecular recognition usually targeting 
agents are attached with the surface of nanoparticles for 
molecular recognition. Nanotechnology based targeted 
delivery mainly influence by mainly three targeting 
mechanism apoptosis inducing agent, a targeting moiety-
penetration enhancer and a carrier. Particles containing 
chemotherapeutic agents are engulfed by phagocytes and 
rapidly cleared by the reticuloendothelial system (RES)32. 
Nanoparticles can also be sustained in blood stream with 
hydrophilic coated polymer that can sufficiently target 
cancerous cells. Nanoparticle mostly target cancerous cells 
as some receptors are over expressed on the surface of them 
that make the distinguishing feature33. Cancerous cells are 
targeted by attachment of complementary ligands on the 
surface of nanoparticles. After the binding of nanoparticles 
with the receptor it undergoes receptor-mediated 
endocytosis or phagocytosis by cells, resulting in cell 
internalization of the encapsulated drug. 
 
 
Fig 3: Shows active targeting of nanoparticle through drug delivery system 
 
4. Preparation techniques of nanoparticles 
4.1 Solvent Evaporation 
 In this process the polymer is dissolved in organic solvent 
(dichloromethane, chloroform or ethyl acetate) and drug is 
dispersed in solution drop wise. Then this mixture is added 
in an aqueous phase containing surfactant (polysorbates, 
poloxamers sodium dodecyl sulfates polyvinyl alcohol, 
gelatin) to make an emulsion by using mechanical stirring, 
sonication, or homogenizer. After formation of emulsion the 
organic solvent evaporates with continuous stirring34. This 
procedure is known as single emulsion solvent evaporation 
method. For double emulsion method the mixture is 
emulsified in aqueous phase containing surfactant (w/o) 
then pour in surfactant having different concentration 
(w/o/w)   stir overnight for evaporation of organic solvent 
and centrifuge after 5 hours.  
4.3 Nanoprecipitation method  
This method was first described by Fessi at al. 198935 also 
known as solvent displacement method. This technique 
included precipitation of polymer and drug. Firstly drug was 
dissolved in water, then the inner phase was formed by 
addition of solvent into this solution. The drug solution was 
dispersed with another solution prepared with polymer such 
as ethyl cellulose and propylene glycol mixed in chloroform 
.This dispersion was slowly added to 10 ml of 70% aqueous 
ethanol solution mixed for 5 minutes. The solution was kept 
at 35 degree C under normal pressure for removal of the 
organic solvents. Then the solution was centrifuge at 10000 
rpm for 4 degree C for 20 min supernatant were removed 
and nanoparticles washed with water and dried at room 
temperature in a desicator36. 
4.4 Ionic gelation method 
Ionic gelation method involves two aqueous phases First 
phase contain biodegradable hydrophilic polymers  like 
chitosan, gelatin and sodium alginate and  second phase 
contain poly anion sodium tripolyphosphate the electrostatic 
interaction between these two phases result in formation of 
forms coacervates38. Various nanoparticles using drugs like 
Prednisone, Acyclovir have been prepared using chitosan, 
pectin- calcium chloride and sodium alginate, calcium 
chloride have been prepared for control drug release and 
gastroretentive drug delivery beads respectively39. Insulin 
loaded nanoparticle using arabic gum were prepared for 
diabetes patients. Chitosan was dissolved in 1.0% acetic acid 
under stirring at room temperature. For preparation of 
nanoparticle arabic gum was added dropwise with the help 
of syringe to chitosan solution containing insulin under 
gentle magnetic stirring at room temperature. 
The nanoparticle suspension was centrifuged for 15 min at 
14,000 rpm at 4°C39. 
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Fig: 4 Representation of double emulsion solvent evaporation method 
  
 4.5 Salting Out Method 
 This technique involves preparation of nanoparticles by 
addition of polymer and drug in a solvent usually acetone 
emulsified into a aqueous solution containing salting out 
agent such as magnesium chloride and calcium chloride. 
After the formation of emulsion water is added for complete 
diffusion of acetone which results in forming nanosphere. 
The technique of separating water miscible solvent from 
aqueous solution is known salting out effect40. Poly vinyl 
alcohol, polyvinyl pyrrolidone or hydroxyethyl cellulose are 
also used as colloidal, emulsion stabilizer for production of 
salting out effect by saturation of aqueous phase. The 
technique does not require any stirring energy or 
temperature for lowering particle size. The technique does 
not show effective response lipophilic drug. 
5. Influence of nanotechnology on herbal drugs 
Nanotechnology has shown tremendous success over 
synthetic drug through nanocarriers for targeted drug 
delivery system. Recently pharmaceutical scientists have 
focused on delivery of herbal drug through nanocarriers 
using a scientific approach.  Various traditional Chinese and 
Indian medicines came into limelight during the study for 
treatment of various diseases such as cancer .The most 
commonly used traditional Chinese medicine Cuscuta 
chinensis nourish the liver and kidney but due to the poor 
water solubility of its major constituents such as flavonoids 
and lignans, limits its absorption by oral route. Thus 
nanoparticles for the same were developed to overcome the 
limitation and successful administration of drug through 
oral route without hindering the absorption of 
constituents41. In recent years various experimental studies 
have been taken for study of herbal drug with and without 
nanocarriers. Cucurbitacins and Curcuminoids lipophilic 
anticancer herbal drug were encapsulated with polylactic 
acid using a precipitation for effective delivery to cancer42. 
Traditional Chinese medicines have been encapsulated in 
nano formulation form and have been characterized for their 
targeted delivery and increased bioavailability and efficacy. 
In the recent years, Triptolide an herbal medicine was 
encapsulated in form of polymeric nanoparticles to enhance 
the solubility and reduce the toxicity for treatment of 
antineoplastic activity other than this curcumin a natural 
polyphenol encapsulated in form polymeric nanoparticle to 
bioavailability and solubility for antitumor activity. 
6. Conclusions and future perspectives 
Nanotechnology is assumed to be a fundamental setting in 
drug delivery system and human therapeutics. Nanocarriers 
have shown wonder in herbal and synthetic drugs delivery 
system especially in anticancer activity. Various limitations 
associated with conventional chemotherapy have been 
overcome by use of nanocarrier-based drug delivery 
systems. Nano carriers help to improve the bioavailability 
and therapeutic efficiency of antitumor drugs, while 
providing preferential accumulation at the target site. 
However, clinical practices are yet a challenge yet to be 
achieved. Human trials need to be conducted to establish 
effectiveness in clinical applications as an improved 
therapeutic modality for treatment of different disease 
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